Clinical Trial Update: Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial testing becotatug vedotin in combination with cetuximab for later-line treatment of metastatic RAS wild-type co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Becotatug Vedotin
• Cetuximab (cetuximab)

Snippet

Sponsor: Fudan University | Conditions: RAS Wild Type mCRC | Phase 2 | Status: NOT_YET_RECRUITING